ONCS good stuff.
Ok I get what the shareholder-writer puts out. Rosy view. Only thing maybe is how he has cash flow $9M. Could be, I only saw Yahoo at op cash flow -$9.3M mrq. Cash $4.93M. Numbers on little plays can be a mine field though so that's already factored in. It's trading on promise not current condition.
Over all it does look like an under covered play. Just have to be careful with any low priced stock. Street doesn't get fooled too ofter. If rips to 0.30 that would acknowledge the mspricing at this point - suggesting more to come.
Enterprise Value (Apr 7, 2013) 20.48M right now at Yahoo so writer is talking up a 10X play. Pretty heady stuff ahead since ttm is trailing 12 months (back view). g/l
OncoSec Medical is a tremendously undervalued company. It has a capitalization of $27MM and a cash flow of $9MM. Besides, it is carrying out several major studies. Immunopulse and Neopulse treatments can provide it with an income of $500MM annually minimum. This enterprise should have a minimum capitalization of $250MM or $2.5 per share.
*Pipeline overview data sourced from OncoSec Medical, all other data sourced from Nasdaq.com, CNN Money as well as the web of the previously mentioned company.
News 
Market Data 
Discover 
